Julian Robertson T2 Biosystems, Inc. Transaction History

Tiger Management L.L.C.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$2.56 - $4.48 $2.1 Million - $3.68 Million	-820,499 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$2.98 - $6.86 $438,316 - $1.01 Million	-147,086 Reduced 15.2%	820,499 $2.47 Million
Q3 2018 Nov 14, 2018	SELL	$5.36 - $7.83 $206,842 - $302,159	-38,590 Reduced 3.84%	967,585 $7.21 Million
Q2 2018 Aug 14, 2018	SELL	$5.97 - $9.58 $6.04 Million - $9.69 Million	-1,011,397 Reduced 50.13%	1,006,175 $7.79 Million
Q1 2018 May 15, 2018	SELL	$4.21 - $7.0 $1.28 Million - $2.13 Million	-304,228 Reduced 13.1%	2,017,572 $13.1 Million
Q4 2017 Feb 14, 2018	BUY	$3.73 - $4.6 $1.22 Million - $1.5 Million	327,115 Added 16.4%	2,321,800 $9.57 Million
Q3 2017 Nov 14, 2017	BUY	$3.9 - $6.78 $7.78 Million - $13.5 Million	1,994,685	1,994,685 $8.38 Million

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $3.38M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Tiger Management L.L.C., based on Form 13F filings with the SEC.

Stay updated on Tiger Management L.L.C. and Julian Robertson with notifications on news.